Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1103

1.

Artificial Intelligence-assisted System Improves Endoscopic Identification of Colorectal Neoplasms.

Kudo SE, Misawa M, Mori Y, Hotta K, Ohtsuka K, Ikematsu H, Saito Y, Takeda K, Nakamura H, Ichimasa K, Ishigaki T, Toyoshima N, Kudo T, Hayashi T, Wakamura K, Baba T, Fumio I, Inoue H, Itoh H, Oda M, Mori K.

Clin Gastroenterol Hepatol. 2019 Sep 13. pii: S1542-3565(19)30997-8. doi: 10.1016/j.cgh.2019.09.009. [Epub ahead of print]

PMID:
31525512
2.

EGFR-TKI acquired resistance in lung cancers harboring EGFR mutations in immunocompetent C57BL/6J mice.

Higo H, Ohashi K, Makimoto G, Nishii K, Kudo K, Kayatani H, Watanabe H, Kano H, Ninomiya K, Hotta K, Maeda Y, Kiura K.

Lung Cancer. 2019 Aug 20;136:86-93. doi: 10.1016/j.lungcan.2019.08.019. [Epub ahead of print]

PMID:
31470227
3.

Primary non-ampullary duodenal follicular lymphoma presenting with obstructive jaundice.

Sato J, Ishiwatari H, Ashida R, Sasaki K, Fujie S, Kaneko J, Satoh T, Matsubayashi H, Kishida Y, Yoshida M, Ito S, Kawata N, Imai K, Kakushima N, Takizawa K, Hotta K, Uesaka K, Ono H.

Clin J Gastroenterol. 2019 Aug 10. doi: 10.1007/s12328-019-01033-2. [Epub ahead of print]

PMID:
31401784
4.

A Risk Prediction Model in Asymptomatic Patients with Severe Aortic Stenosis: CURRENT-AS risk score.

Minamino-Muta E, Kato T, Morimoto T, Taniguchi T, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Miyake M, Izumi C, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Inoko M, Ikeda T, Ishii K, Hotta K, Jinnai T, Kato Y, Inuzuka Y, Maeda C, Morikami Y, Saito N, Minatoya K, Kimura T.

Eur Heart J Qual Care Clin Outcomes. 2019 Aug 6. pii: qcz044. doi: 10.1093/ehjqcco/qcz044. [Epub ahead of print]

PMID:
31386103
5.

The Input-Output Relationship of AIY Interneurons in Caenorhabditis elegans in Noisy Environment.

Ashida K, Hotta K, Oka K.

iScience. 2019 Jul 23;19:191-203. doi: 10.1016/j.isci.2019.07.028. [Epub ahead of print]

6.

Rapid Acquisition of Alectinib Resistance in ALK-Positive Lung Cancer With High Tumor Mutation Burden.

Makimoto G, Ohashi K, Tomida S, Nishii K, Matsubara T, Kayatani H, Higo H, Ninomiya K, Sato A, Watanabe H, Kano H, Ninomiya T, Kubo T, Rai K, Ichihara E, Hotta K, Tabata M, Toyooka S, Takata M, Maeda Y, Kiura K.

J Thorac Oncol. 2019 Jul 30. pii: S1556-0864(19)30602-1. doi: 10.1016/j.jtho.2019.07.017. [Epub ahead of print]

PMID:
31374369
7.

Reasons for Choosing Conservative Management in Symptomatic Patients With Severe Aortic Stenosis - Observations From the CURRENT AS Registry.

Ishii M, Taniguchi T, Morimoto T, Ogawa H, Masunaga N, Abe M, Yoshikawa Y, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Jinnai T, Morikami Y, Akao M, Minatoya K, Kimura T; CURRENT AS Registry Investigators.

Circ J. 2019 Aug 23;83(9):1944-1953. doi: 10.1253/circj.CJ-19-0247. Epub 2019 Jul 17.

8.

Impact of pathological stage and histological subtype on clinical outcome of adjuvant chemotherapy of paclitaxel plus carboplatin versus oral uracil-tegafur for non-small cell lung cancer: subanalysis of SLCG0401 trial.

Soh J, Toyooka S, Okumura N, Nakamura H, Nakata M, Yamashita M, Sakamoto J, Aoe M, Hotta K, Morita S, Date H.

Int J Clin Oncol. 2019 Jul 16. doi: 10.1007/s10147-019-01508-9. [Epub ahead of print]

PMID:
31312931
9.

Continuous Anticoagulation and Cold Snare Polypectomy Versus Heparin Bridging and Hot Snare Polypectomy in Patients on Anticoagulants With Subcentimeter Polyps: A Randomized Controlled Trial.

Takeuchi Y, Mabe K, Shimodate Y, Yoshii S, Yamada S, Iwatate M, Kawamura T, Hotta K, Nagaike K, Ikezawa N, Yamasaki T, Komeda Y, Asai S, Abe Y, Akamatsu T, Sakakibara Y, Ikehara H, Kinjo Y, Ohta T, Kitamura Y, Shono T, Inoue T, Ohda Y, Kobayashi N, Tanuma T, Sato R, Sakamoto T, Harada N, Chino A, Ishikawa H, Nojima M, Uraoka T; Madowazu Study Group.

Ann Intern Med. 2019 Jul 16. doi: 10.7326/M19-0026. [Epub ahead of print]

PMID:
31307055
10.

MR signal changes in superparamagnetic iron oxide nanoparticle-labeled macrophages in response to X irradiation.

Yamaguchi M, Ohnuki K, Hotta K, Fujii H.

NMR Biomed. 2019 Sep;32(9):e4132. doi: 10.1002/nbm.4132. Epub 2019 Jul 15.

PMID:
31305958
11.

A Long-term Response to Nivolumab in a Case of PD-L1-negative Lung Adenocarcinoma with an EGFR Mutation and Surrounding PD-L1-positive Tumor-associated Macrophages.

Watanabe H, Ohashi K, Nishii K, Seike K, Makimoto G, Hotta K, Maeda Y, Kiura K.

Intern Med. 2019 Jul 10. doi: 10.2169/internalmedicine.2875-19. [Epub ahead of print]

12.

Liver phantom design and dosimetric verification in participating institutions for a proton beam therapy in patients with resectable hepatocellular carcinoma: Japan Clinical Oncology Group trial (JCOG1315C).

Nishio T, Tachibana H, Kase Y, Hotta K, Nakamura M, Tamura M, Terunuma T, Toshito T, Yamashita H, Ishikura S, Fuji H, Akimoto T, Nishimura Y.

Radiother Oncol. 2019 Jun 29;140:98-104. doi: 10.1016/j.radonc.2019.06.005. [Epub ahead of print]

PMID:
31265942
13.

Successful Treatment of Metastatic Urothelial Carcinoma after Accurate Diagnosis by Immunohistochemistry.

Makimoto G, Nishimori H, Kondo R, Yanai H, Sugimoto M, Oda N, Kubo T, Hotta K, Tabata M, Kiura K, Maeda Y.

Acta Med Okayama. 2019 Jun;73(3):279-284. doi: 10.18926/AMO/56873.

14.

Preoperative indicators of misdiagnosis in invasion depth staging of esophageal cancer: Pitfalls of magnifying endoscopy with narrow-band imaging.

Kimura H, Yoshida M, Tanaka M, Kawata N, Kakushima N, Takizawa K, Kishida Y, Imai K, Ito S, Hotta K, Ishiwatari H, Matsubayashi H, Ono H.

Dig Endosc. 2019 Jun 17. doi: 10.1111/den.13464. [Epub ahead of print]

PMID:
31206847
15.

Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer.

Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum.

Int J Clin Oncol. 2019 Jun 15. doi: 10.1007/s10147-019-01485-z. [Epub ahead of print]

PMID:
31203527
16.

Programmed cell death-ligand 1 expression and efficacy of cisplatin-based chemotherapy in lung cancer: A sub-analysis of data from the two Okayama Lung Cancer Study Group prospective feasibility studies.

Nishii K, Hotta K, Ninomiya K, Kato Y, Ichihara E, Ohashi K, Ninomiya T, Kubo T, Rai K, Tabata M, Maeda Y, Kiura K.

Respir Investig. 2019 Sep;57(5):460-465. doi: 10.1016/j.resinv.2019.04.004. Epub 2019 Jun 8.

PMID:
31186170
17.

Daily Passive Muscle Stretching Improves Flow-Mediated Dilation of Popliteal Artery and 6-minute Walk Test in Elderly Patients with Stable Symptomatic Peripheral Artery Disease.

Hotta K, Batchelor WB, Graven J, Dahya V, Noel TE, Ghai A, Katopodis JN, Dixon WC, Andrews R, Pragle A, Chheda J, Liberatore L, Behnke BJ, Muller-Delp J.

Cardiovasc Revasc Med. 2019 Aug;20(8):642-648. doi: 10.1016/j.carrev.2019.05.003. Epub 2019 May 10.

PMID:
31171470
18.

Hypofractionated proton beam therapy for centrally located lung cancer.

Nakamura N, Hotta K, Zenda S, Baba H, Kito S, Akita T, Motegi A, Hojo H, Nakamura M, Parshuram RV, Okumura M, Akimoto T.

J Med Imaging Radiat Oncol. 2019 Aug;63(4):552-556. doi: 10.1111/1754-9485.12901. Epub 2019 May 30.

PMID:
31145553
19.

The benefit of exercise in patients who undergo allogeneic hematopoietic stem cell transplantation.

Morishita S, Tsubaki A, Hotta K, Fu JB, Fuji S.

J Int Soc Phys Rehabil Med. 2019 Jan-Mar;2(1):54-61. doi: 10.4103/jisprm.jisprm_2_19. Epub 2019 May 22.

PMID:
31131374
21.

Re-administration of osimertinib in osimertinib-acquired resistant non-small-cell lung cancer.

Ichihara E, Hotta K, Ninomiya K, Kubo T, Ohashi K, Rai K, Tanaka H, Tabata M, Maeda Y, Kiura K.

Lung Cancer. 2019 Jun;132:54-58. doi: 10.1016/j.lungcan.2019.02.021. Epub 2019 Apr 6.

PMID:
31097094
22.

The effect and safety of immune checkpoint inhibitor rechallenge in non-small cell lung cancer.

Watanabe H, Kubo T, Ninomiya K, Kudo K, Minami D, Murakami E, Ochi N, Ninomiya T, Harada D, Yasugi M, Ichihara E, Ohashi K, Fujiwara K, Hotta K, Tabata M, Maeda Y, Kiura K.

Jpn J Clin Oncol. 2019 May 15. pii: hyz066. doi: 10.1093/jjco/hyz066. [Epub ahead of print]

PMID:
31090906
23.

Multiple tracking and machine learning reveal dopamine modulation for area-restricted foraging behaviors via velocity change in Caenorhabditis elegans.

Ashida K, Kato T, Hotta K, Oka K.

Neurosci Lett. 2019 Jul 27;706:68-74. doi: 10.1016/j.neulet.2019.05.011. Epub 2019 May 10.

PMID:
31082452
24.

Fascial plane blocks: anatomical structures that affect the spread of local anesthetic.

Hotta K.

J Anesth. 2019 Aug;33(4):493-494. doi: 10.1007/s00540-019-02647-z. Epub 2019 May 9. No abstract available.

PMID:
31073655
25.

A Prospective Cohort Study to Define the Clinical Features and Outcome of Lung Cancers Harboring HER2 Aberration in Japan (HER2-CS STUDY).

Ninomiya K, Hata T, Yoshioka H, Ohashi K, Bessho A, Hosokawa S, Ishikawa N, Yamasaki M, Shibayama T, Aoe K, Kozuki T, Harita S, Ueda Y, Murakami T, Fujimoto N, Yanai H, Toyooka S, Takata M, Hotta K, Kiura K; HER2-CS Network.

Chest. 2019 Aug;156(2):357-366. doi: 10.1016/j.chest.2019.01.011. Epub 2019 May 6.

PMID:
31072612
26.

Arthroscopic capsular repair using proximal advancement for instability following hip arthroscopic surgery: a case report.

Nishikino S, Hoshino H, Hotta K, Furuhashi H, Koyama H, Matsuyama Y.

J Hip Preserv Surg. 2019 Feb 25;6(1):91-96. doi: 10.1093/jhps/hnz007. eCollection 2019 Jan.

27.

Percentage of CD19+ Cells in Peripheral Blood Lymphocytes After Rituximab-Based Desensitization as a Predictor of Acute Antibody-Mediated Rejection in ABO-Incompatible Kidney Transplantation.

Hirose T, Iwami D, Hotta K, Sasaki H, Higuchi H, Shinohara N.

Transplant Proc. 2019 Jun;51(5):1382-1386. doi: 10.1016/j.transproceed.2019.01.127. Epub 2019 Apr 23.

PMID:
31027828
28.

A 2-mm Cutoff Value Is Reasonable and Feasible for Vascular Reconstruction in a Kidney Allograft With Multiple Arteries.

Iwami D, Hotta K, Sasaki H, Hirose T, Higuchi H, Takada Y, Iwahara N, Shinohara N.

Transplant Proc. 2019 Jun;51(5):1317-1320. doi: 10.1016/j.transproceed.2019.01.137. Epub 2019 Apr 23.

PMID:
31027827
29.

Physician requests by patients with malignant pleural mesothelioma in Japan.

Nagamatsu Y, Oze I, Aoe K, Hotta K, Kato K, Nakagawa J, Hara K, Kishimoto T, Fujimoto N.

BMC Cancer. 2019 Apr 25;19(1):383. doi: 10.1186/s12885-019-5591-7.

30.

Corrigendum to "Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan" [Lung Cancer, 129 (March) (2019) 55-62].

Watanabe S, Yoshioka H, Sakai H, Hotta K, Takenoyama M, Yamada K, Sugawara S, Takiguchi Y, Hosomi Y, Tomii K, Niho S, Yamamoto N, Nishio M, Ohe Y, Kato T, Takahashi T, Kamada A, Suzukawa K, Omori Y, Enatsu S, Nakagawa K, Tamura T.

Lung Cancer. 2019 Jun;132:157-158. doi: 10.1016/j.lungcan.2019.04.010. Epub 2019 Apr 20. No abstract available.

31.

Recent trends in the treatment of unresectable stage III non-small-cell lung cancer.

Makimoto G, Hotta K, Kiura K.

Respir Investig. 2019 Jul;57(4):330-336. doi: 10.1016/j.resinv.2019.03.004. Epub 2019 Apr 15. Review.

PMID:
31000495
32.

Intrawound vancomycin powder increases post-operative wound complications and does not decrease periprosthetic joint infection in primary total and unicompartmental knee arthroplasties.

Hanada M, Nishikino S, Hotta K, Furuhashi H, Hoshino H, Matsuyama Y.

Knee Surg Sports Traumatol Arthrosc. 2019 Jul;27(7):2322-2327. doi: 10.1007/s00167-019-05498-z. Epub 2019 Apr 9.

PMID:
30968239
33.

A phase I/II trial of weekly nab-paclitaxel for pretreated non-small-cell lung cancer patients without epidermal growth factor receptor mutations and anaplastic lymphoma kinase rearrangement.

Harada D, Kozuki T, Nogami N, Bessho A, Hosokawa S, Fukamatsu N, Hotta K, Ohashi K, Kubo T, Yoshioka H, Yokoyama T, Sone N, Kuyama S, Kudo K, Yasugi M, Takigawa N, Oze I, Kiura K.

Asia Pac J Clin Oncol. 2019 Aug;15(4):250-256. doi: 10.1111/ajco.13147. Epub 2019 Apr 1.

PMID:
30938103
34.

Timing of surgical interventions for upper cervical epidural abscess: a case report and review of the literature.

Kobayashi T, Ureshino H, Hotta K, Ikuta K.

Eur J Orthop Surg Traumatol. 2019 Aug;29(6):1365-1366. doi: 10.1007/s00590-019-02425-3. Epub 2019 Mar 26. No abstract available.

PMID:
30915554
35.

A huge inflammatory fibroid polyp: an unexpected finding after positive fecal immunochemical test.

Kimura H, Imai K, Hotta K, Ito S, Kishida Y, Ono H.

Endoscopy. 2019 Jun;51(6):E147-E148. doi: 10.1055/a-0862-0133. Epub 2019 Mar 25. No abstract available.

PMID:
30909300
36.

A novel compound heterozygous mutation in TTC8 identified in a Japanese patient.

Sato S, Morimoto T, Hotta K, Fujikado T, Nishida K.

Hum Genome Var. 2019 Mar 12;6:14. doi: 10.1038/s41439-019-0045-y. eCollection 2019.

37.

Recent treatment strategy for advanced squamous cell carcinoma of the lung in Japan.

Senoo S, Ninomiya K, Hotta K, Kiura K.

Int J Clin Oncol. 2019 May;24(5):461-467. doi: 10.1007/s10147-019-01424-y. Epub 2019 Mar 7. Review.

PMID:
30847617
38.

Necitumumab plus gemcitabine and cisplatin versus gemcitabine and cisplatin alone as first-line treatment for stage IV squamous non-small cell lung cancer: A phase 1b and randomized, open-label, multicenter, phase 2 trial in Japan.

Watanabe S, Yoshioka H, Sakai H, Hotta K, Takenoyama M, Yamada K, Sugawara S, Takiguchi Y, Hosomi Y, Tomii K, Niho S, Yamamoto N, Nishio M, Ohe Y, Kato T, Takahashi T, Kamada A, Suzukawa K, Omori Y, Enatsu S, Nakagawa K, Tamura T.

Lung Cancer. 2019 Mar;129:55-62. doi: 10.1016/j.lungcan.2019.01.005. Epub 2019 Jan 16. Erratum in: Lung Cancer. 2019 Jun;132:157-158.

39.

Chemoradiotherapy for locally advanced lung cancer patients with interstitial lung abnormalities.

Higo H, Kubo T, Makimoto S, Makimoto G, Ihara H, Masaoka Y, Ninomiya T, Ichihara E, Ohashi K, Sato A, Hotta K, Tabata M, Takigawa N, Maeda Y, Kiura K.

Jpn J Clin Oncol. 2019 May 1;49(5):458-464. doi: 10.1093/jjco/hyz016.

PMID:
30793176
40.

Anemia in Patients with Severe Aortic Stenosis.

Nagao K, Taniguchi T, Morimoto T, Shiomi H, Ando K, Kanamori N, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Inada T, Murakami T, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Kimura T; CURRENT AS Registry Investigators.

Sci Rep. 2019 Feb 13;9(1):1924. doi: 10.1038/s41598-018-36066-z.

41.

A novel thin wire snare-assisted en bloc cold snare endoscopic mucosal resection of a colonic adenoma 10-14 mm in size.

Yabuuchi Y, Imai K, Hotta K.

Dig Endosc. 2019 May;31(3):e76-e77. doi: 10.1111/den.13370. Epub 2019 Mar 12. No abstract available.

PMID:
30740773
42.

Beneficial Effect of Osimertinib Readministration in Non-small-cell Lung Cancer Harboring an Epidermal Growth Factor Receptor (EGFR) Mutation with a History of Acquired Resistance to Osimertinib.

Makimoto G, Ohashi K, Senoo S, Hotta K, Maeda Y, Kiura K.

Intern Med. 2019 Jun 1;58(11):1625-1627. doi: 10.2169/internalmedicine.2152-18. Epub 2019 Feb 1.

43.

Prognostic Impact of Aortic Valve Area in Conservatively Managed Patients With Asymptomatic Severe Aortic Stenosis With Preserved Ejection Fraction.

Kanamori N, Taniguchi T, Morimoto T, Watanabe H, Shiomi H, Ando K, Murata K, Kitai T, Kawase Y, Izumi C, Miyake M, Mitsuoka H, Kato M, Hirano Y, Matsuda S, Nagao K, Inada T, Mabuchi H, Takeuchi Y, Yamane K, Toyofuku M, Ishii M, Minamino-Muta E, Kato T, Inoko M, Ikeda T, Komasa A, Ishii K, Hotta K, Higashitani N, Kato Y, Inuzuka Y, Maeda C, Jinnai T, Morikami Y, Saito N, Minatoya K, Aoyama T, Kimura T; CURRENT AS Registry Investigators.

J Am Heart Assoc. 2019 Feb 5;8(3):e010198. doi: 10.1161/JAHA.118.010198.

44.

Benefit of high negative pressure during endoscopic ultrasound-guided fine-needle aspiration with standard 22-gauge needles for pancreatic lesions: a retrospective comparative study.

Sato J, Ishiwatari H, Sasaki K, Fujie S, Kaneko J, Satoh T, Matsubayashi H, Kishida Y, Yoshida M, Ito S, Kawata N, Imai K, Kakushima N, Takizawa K, Hotta K, Ono H.

Scand J Gastroenterol. 2019 Jan;54(1):108-113. doi: 10.1080/00365521.2018.1564788. Epub 2019 Jan 24.

PMID:
30676114
45.

An Unusual Lesion of the Colon Resembling a Submucosal Tumor.

Yabuuchi Y, Hotta K, Aizawa D.

Gastroenterology. 2019 May;156(6):1578-1579. doi: 10.1053/j.gastro.2019.01.009. Epub 2019 Jan 11. No abstract available.

PMID:
30641056
46.

Magnified endoscopy with narrow-band imaging for the differential diagnosis of superficial non-ampullary duodenal epithelial tumors.

Kakushima N, Yoshida M, Yamaguchi Y, Takizawa K, Kawata N, Tanaka M, Kishida Y, Ito S, Imai K, Hotta K, Ishiwatari H, Matsubayashi H, Sasaki K, Ono H.

Scand J Gastroenterol. 2019 Jan;54(1):128-134. doi: 10.1080/00365521.2018.1557740. Epub 2019 Jan 13.

PMID:
30638088
47.

Effect of 5-fluorouracil on cellular response to proton beam in esophageal cancer cell lines according to the position of spread-out Bragg peak.

Hojo H, Dohmae T, Hotta K, Kageyama SI, Baba H, Kohno R, Motegi A, Tsuchihara K, Akimoto T.

Acta Oncol. 2019 Apr;58(4):475-482. doi: 10.1080/0284186X.2018.1555373. Epub 2019 Jan 11.

PMID:
30632869
48.

Rupture of Pseudoaneurysm after Biliary Metallic Stent Placement.

Satoh T, Matsubayashi H, Ishiwatari H, Fujie S, Kaneko J, Sato J, Ito S, Kishida Y, Imai K, Hotta K, Yoshida M, Kawata N, Takizawa K, Kakushima N, Sawada A, Ono H.

Intern Med. 2019 May 15;58(10):1453-1457. doi: 10.2169/internalmedicine.1862-18. Epub 2019 Jan 10.

49.

Updated Analysis of KEYNOTE-024: Pembrolizumab Versus Platinum-Based Chemotherapy for Advanced Non-Small-Cell Lung Cancer With PD-L1 Tumor Proportion Score of 50% or Greater.

Reck M, Rodríguez-Abreu D, Robinson AG, Hui R, Csőszi T, Fülöp A, Gottfried M, Peled N, Tafreshi A, Cuffe S, O'Brien M, Rao S, Hotta K, Vandormael K, Riccio A, Yang J, Pietanza MC, Brahmer JR.

J Clin Oncol. 2019 Mar 1;37(7):537-546. doi: 10.1200/JCO.18.00149. Epub 2019 Jan 8.

PMID:
30620668
50.

Spinal myoclonus following neuraxial anesthesia: a literature review.

Shiratori T, Hotta K, Satoh M.

J Anesth. 2019 Feb;33(1):140-147. doi: 10.1007/s00540-018-02607-z. Epub 2019 Jan 6. Review.

PMID:
30613902

Supplemental Content

Support Center